Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06051942 · ClinicalTrials.gov registry record · NA

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

A NA study of Benign Prostatic Hyperplasia and Localized Prostate Cancer, sponsored by PROCEPT BioRobotics.

Active
Registry status
NA
Development phase
125
Enrollment target
6
Study locations

NCT06051942 is a NA study of Benign Prostatic Hyperplasia and Localized Prostate Cancer that is active but no longer recruiting, run by PROCEPT BioRobotics. The registered enrollment target is 125 participants, below the 548-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (77% lower). The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06051942, a NA study of Benign Prostatic Hyperplasia and Localized Prostate Cancer, is active but no longer recruiting, sponsored by PROCEPT BioRobotics.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
6
Study locations

Study Summary

The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.

Conditions Studied

Benign Prostatic Hyperplasia Localized Prostate Cancer

Interventions

  • DEVICE Robotic Waterjet Treatment

Study Locations (6)

Other

  • The Chinese University of Hong Kong - Hong Kong
  • American University of Beirut - Beirut
  • Tauranga Urology Research Ltd - Tauranga

California

  • San Diego Clinical Trials - La Mesa

Illinois

  • Endeavour Health (NorthShore University HealthSystem) - Glenview

Virginia

  • Potomac Urology Center - Alexandria

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2022-11-22
Est. Completion 2027-03
Phase NA

Sponsor

PROCEPT BioRobotics

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06051942

The ClinicalTrials.gov registry entry for NCT06051942 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 548-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (77% lower). The listed sponsor is PROCEPT BioRobotics, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 1 intervention - of which Robotic Waterjet Treatment is the first listed.

NCT06051942 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Other, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT06051942 about?

NCT06051942 is a clinical study titled "PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs". The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline...

What is the current status of trial NCT06051942?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2022-11-22. Estimated completion is 2027-03.

What conditions does trial NCT06051942 study?

This clinical trial studies the following conditions: Benign Prostatic Hyperplasia, Localized Prostate Cancer.

What interventions are being tested in trial NCT06051942?

The interventions under investigation include: Robotic Waterjet Treatment (DEVICE).

Who is sponsoring clinical trial NCT06051942?

This trial is sponsored by PROCEPT BioRobotics, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06051942 being conducted?

This trial has 6 study locations across California, Illinois, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Benign Prostatic Hyperplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Benign Prostatic Hyperplasia

All registered trials for this condition

Localized Prostate Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.